In a sheep model of tachypacing-induced AF, they tested the effects of Gal-3 inhibition during AF progression and found that Gal-3 was higher in animals with persistent AF, and the Gal-3 inhibitor GM-CT-01 decreased overall AF burden [36]. The gene discussed is LGALS3; the disease is atrial fibrillation.